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Abstract
Interferon-γ (IFN-γ) primes macrophages for enhanced inflammatory activation by Toll-like 
receptors (TLRs) and microbial killing, but little is known about the regulation of cell metabolism 
or mRNA translation during priming. We found that IFN-γ regulates human macrophage 
metabolism and translation by targeting the kinases mTORC1 and MNK that both converge on the 
selective regulator of translation initiation eIF4E. Physiological downregulation of mTORC1 by 
IFN-γ was associated with autophagy and translational suppression of repressors of inflammation 
such as HES1. Genome-wide ribosome profiling in TLR2-stimulated macrophages revealed that 
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IFN-γ selectively modulates the macrophage translatome to promote inflammation, further 
reprogram metabolic pathways, and modulate protein synthesis. These results add IFN-γ-mediated 
metabolic reprogramming and translational regulation as key components of classical 
inflammatory macrophage activation.
Interferon-γ (IFN-γ) activates innate responses by augmenting inflammatory cytokine and 
chemokine production, microbial killing, and antigen presentation by mononuclear 
phagocytes such as macrophages1. Immune cell activation by IFN-γ is entirely dependent on 
its activation of the transcription factor STAT1, which binds to and activates transcription of 
interferon-stimulated genes (ISGs)2. Direct and rapid activation of ISGs plays a key role in 
IFN-γ-mediated functions2. It has become clear that many IFN-γ activities can not be 
explained by the direct effector functions of ISGs, and that important IFN-γ functions are 
mediated by crossregulation of distinct signaling pathways or reprogramming of cell states 
to alter their responses to extracellular stimuli1. For example, IFN-γ- augments macrophage 
cytokine production in response to inflammatory stimuli such as TLR ligands1 by 
attenuating signaling via the suppressive transcription factor STAT33, and by inhibiting 
expression of the TLR-induced Notch-dependent transcriptional repressors HES1 and 
HEY14. In parallel, IFN-γ reprograms the ‘epigenetic landscape’ of macrophages by 
inducing and priming enhancers to increase transcriptional output in response to TLR 
signaling5, 6. Whether IFN-γ can reprogram macrophage metabolism to alter cell function 
remains to be elucidated.
The importance of translational control of immune responses is increasingly appreciated7. 
Increased translation of select cytokine, chemokine and transcription factor mRNAs has 
been observed after TLR stimulation8, 9, and key immune regulators such as I-κBα and 
IRF7 are under translational control10, 11. Selective translational regulation of mRNA 
transcripts typically occurs at the level of initiation and can be achieved by specific RNA-
binding proteins, microRNAs, and by modulation of the activity of 5’ cap-binding 
eukaryotic initiation factor 4E (eIF4E)7. Although eIF4E is a general translation initiation 
factor, changes in its activity do not globally regulate translation but instead selectively 
affect translation of a subset of transcripts, including inefficiently translated transcripts with 
long 5’ untranslated regions (UTRs)7, 11, 12. eIF4E activity is regulated by MNK kinases and 
mechanistic target of rapamycin complex 1 (mTORC1)7, and thus is responsive to upstream 
signals that activate MAPK signaling or mTORC1 activity. Type I IFNs suppress 
translation13 by inactivating translation factor eIF2α14 and inducing ISGs that translationally 
silence viral RNAs15. IFNs can promote translation of ISGs by various mechanisms16, and 
IFN-γ suppresses translation of a small set of mRNAs17. Little is known about regulation of 
translation by IFN-γ in immune cells.
The mechanistic target of rapamycin (mTOR) serine threonine kinase is a component of 
distinct mTORC1 and mTORC2 complexes, of which mTORC1 is an important regulator of 
mRNA translation18. mTORC1 senses and coordinates cellular responses to the nutrient 
status of extracellular and intracellular microenvironments, and is regulated by growth 
factors, oxygen, stress, and intracellular amino acid and energy levels. mTORC1 activation 
requires binary inputs from growth factor-induced Akt-mediated signaling that activates 
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mTOR, and repletion of intracellular amino acids, which enables translocation of mTORC1 
to lysosomal membranes where mTOR activation occurs18. Under nutrient replete 
conditions, mTORC1 promotes anabolic, biosynthetic and proliferative pathways, including 
protein, lipid and nucleotide synthesis that are required for cell growth18. mTORC1 
promotes protein synthesis by phosphorylating and inactivating negative regulators of eIF4E 
termed 4E-BPs, and by activating kinase p70S6K that phosphorylates ribosome proteins7. 
Understanding of the role of mTORC1 in innate immunity is limited19, 20.
In this study we investigated how IFN-γ alters macrophage cell state to potentiate TLR 
responses. To maximize physiological relevance for human inflammatory conditions, we 
used primary human monocytes and macrophages that play a key role in human 
inflammatory diseases. We found that IFN-γ regulates TLR2 responses in human 
macrophages by suppressing MNKs and mTORC1 and modulating mRNA translation. A 
genome-wide ribosome profiling approach revealed that translational regulation selectively 
affected pathways important for cytokine expression, protein synthesis and cell metabolism. 
Our findings reveal an unrecognized function of IFN-γ to reprogram macrophage 
metabolism to alter inflammatory responses.
RESULTS
Inhibition of HES1 mRNA translation by IFN-γ
It was previously shown that IFN-γ suppresses TLR4-induced expression of transcriptional 
repressors HES1 and HEY1, thereby disrupting a feedback inhibitory loop and augmenting 
production of the inflammatory cytokines IL-6 and IL-124. We tested whether IFN-γ could 
also repress induction of HES1 mRNA by TLR2 in primary human macrophages. 
Stimulation with the TLR2 ligand Pam3CSK4 resulted in HES1 mRNA expression within 1 
h, and its abundance increased in a time-dependent manner (Fig. 1a). In contrast to 10-fold 
repression of TLR4 (lipolysacharride, LPS)-induced HES1 mRNA by IFN-γ 
(Supplementary Fig. 1a), TLR2-induced HES1 transcript amounts were minimally 
suppressed by IFN-γ (Fig. 1a). This observation was consistent among more than 20 human 
blood donors tested, and no statistically significant difference was apparent when we pooled 
data from 23 different donors (Supplementary Fig. 1b). In striking contrast to mRNA 
regulation, TLR2-induced HES1 protein expression was almost completely abrogated by 
IFN-γ (Fig. 1b; HES1 was suppressed by 85.5% in 6 independent experiments, p <0.0001). 
The inhibitory effect of IFN-γ on TLR2-induced HES1 protein expression became apparent 
with 4 h of IFN-γ pre-treatment and was clearly established after 6 h of priming (data not 
shown), which is consistent with previous studies of IFN-γ priming21. The prominent 
discrepancy between HES1 mRNA and protein expression suggests that IFN-γ negatively 
regulates HES1 expression at the protein level.
IFN-γ could downregulate HES1 protein either by suppressing its synthesis or increasing its 
degradation. To distinguish between these possibilities, we first monitored HES1 protein 
half life in control and IFN-γ-treated macrophages, and found that HES1 protein decay rates 
were comparable in both conditions (Supplementary Fig. 1c). We also found that neither 
the proteasome inhibitor MG132 nor autophagosome-lysosome fusion inhibitor Bafilomycin 
A1 reversed the downregulation of HES1 protein amounts by IFN-γ (Supplementary Fig. 
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1d-e), implying that accelerated protein degradation was not responsible for the reduced 
HES1 protein abundance in IFN-γ-treated cells. This suggested that IFN-γ suppressed 
translation of HES1 mRNA. We directly tested this hypothesis by performing sucrose 
gradient centrifugation to track the ribosomal distribution of mRNAs in cytosolic extracts 
from control and IFN-γ-treated macrophages. The frequency of ribosome binding to an 
mRNA corresponds to the translation efficiency of each mRNA molecule, and actively 
translated mRNAs are found in the polysome fractions. IFN-γ had no effect on total mRNA 
amounts associated with heavy polysome fractions 9-12 and a minimal suppressive effect on 
light polysome fractions 6-8, indicating that IFN-γ did not globally and nonspecifically 
suppress translation (Fig. 1c). However, IFN-γ slightly reduced monomeric 80S ribosomes 
(fraction 5) and correspondingly increased mRNA amounts associated with individual 
ribosome 40S and 60S subunits (fractions 3 and 4) (Fig. 1c), implying that IFN-γ might 
suppress translation initiation, which is associated with 80S ribosome assembly, of select 
mRNA transcripts.
A shift in individual mRNAs from heavy polysome to light polysome or monosome 
fractions indicates decreased translation efficiency. Polysome shift analysis of mRNAs 
encoded by specific genes showed that in control TLR2-stimulated macrophages a 
substantial fraction of HES1 mRNA resided in heavy polysome fractions (Fig. 1d, top panel, 
fractions 10-12), indicating efficient translation. In IFN-γ-treated cells the HES1 mRNA 
peak shifted to light polysome fractions (Fig. 1d, top panel, fractions 6-8), indicating 
decreased translational efficiency. As a positive control for the polysome shift analysis, we 
found that mRNA encoded by PABPC1, which is known to be sensitive to translational 
regulation, was strongly shifted to the light polysome and monosome fractions in IFN-γ-
treated macrophages (Fig. 1d, middle panel). Accordingly, IFN-γ suppressed PABPC1 
protein amounts without affecting mRNA levels (Fig. 1e, representative data; PABPC1 was 
suppressed by 68.75% in pooled data from 4 independent experiments, p = 0.01). As a 
specificity control, we found that ACTB mRNA was present in the heavy polysome 
fractions, and thus actively translated, regardless of IFN-γ treatment (Fig. 1d, bottom panel). 
Collectively, the results demonstrate that IFN-γ exerts selective effects on translation 
efficiency of distinct mRNAs, and that IFN-γ inhibits translation of PABPC1 and HES1 
mRNA in primary human macrophages.
IFN-γ attenuates TLR2-induced MAPK-MNK-eIF4E signaling
We wished to test whether IFN-γ inhibits translation by targeting the key regulator of 
translation initiation efficiency eIF4E, which is activated following phosphorylation by 
mitogen activated protein kinase (MAPK) interacting kinases (MNKs)22 (Supplementary 
Fig. 2a). TLR2 stimulation induced activating phosphorylation of MNK1 and eIF4E, which 
was substantially but not completely inhibited by IFN-γ at all time points tested (Fig. 2a) (p-
eIF4E was suppressed by 69% in 6 independent experiments, p = 0.0009; p-MNK1 by 66% 
in 3 independent experiments, p = 0.02). These results show that IFN-γ negatively regulates 
activation of TLR2-induced MNK-eIF4E signaling; the functional importance of this 
suppression was supported by IFN-γ-mediated suppression of translation of the signaling 
inhibitor I-κBα and the transcription factor IRF8, which was previously shown to be 
dependent on the MNK-eIF4E pathway9, 10 (Fig. 2b and Supplementary Fig. 2b-d). These 
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results suggest that MNKs play a role in promoting translation of HES1. We tested this 
notion by inhibiting MNKs or knocking down their expression using siRNAs and measuring 
HES1 expression by immunoblot. The MNK inhibitor CGP57380 strongly suppressed HES1 
protein expression in a dose-dependent manner (Fig. 2c) without affecting HES1 mRNA 
induction (Fig. 2d). Furthermore siRNA-mediated knockdown of MNKs (Supplementary 
Fig. 2e) resulted in diminished phosphorylation of eIF4E and decreased expression of HES1 
(Fig. 2e) without decreasing HES1 mRNA expression (Supplementary Fig. 2f). These data 
indicate that efficient HES1 translation requires MNK-mediated phosphorlyation of eIF4E. 
To gain insight into how IFN-γ suppresses TLR2-induced MNK phosphorylation, we 
examined upstream MAPK activation. IFN-γ attenuated TLR2-induced phosphorylation of 
p38 and ERK MAPKs in primary human macrophages (Fig. 2f), which is consistent with 
our previous results3. These MAPKs are dephosphorylated and inactivated by dual 
specificity phosphatases (DUSPs); accordingly IFN-γ increased baseline and TLR2-induced 
expression of DUSP 1, 2, 4, 8 and 16 (Fig. 2g). A role for phosphatases in attenuation of 
MAPK signaling was further supported by reversal of IFN-γ-mediated dampening of p38 
activation by the phosphatase inhibitor okadaic acid (Supplementary Fig. 2g). Taken 
together, our results suggest that optimal translation of HES1 mRNA requires 
phosphorylation of 5’ mRNA cap-binding protein eIF4E, and that IFN-γ suppresses HES1 
translation in part by attenuating TLR2-induced activation of MAPK-MNK-eIF4E signaling.
IFN-γ suppresses mTORC1 activation and downstream function
Given the partial attenuation of MNK activation by IFN-γ, but near-complete suppression of 
HES1, we hypothesized an involvement of additional signaling pathways in the process. A 
major positive regulator of translation is the mTORC1 complex, which phosphorylates 
eIF4E binding proteins (4E-BPs) to release them from eIF4E and thereby promote 
translation (Supplementary Fig. 2a). Therefore, we tested whether IFN-γ suppressed 
mTORC1 activity. mTORC1 activity is typically assessed by measuring phosphorylation of 
its downstream substrates 4E-BP and p70S6K. As expected, 4E-BP1 was phosphorylated on 
Thr37 and/or Thr46 in cultured macrophages, consistent with mTORC1 activity maintained 
by serum growth factors (Fig. 3a). IFN-γ suppressed basal 4E-BP1 phosphorylation (Fig. 
3a, lane 6 vs. lane 1; 52% mean suppression in 7 independent experiments, p = 0.0036) and 
diminished 4E-BP1 phosphorylation was maintained throughout the time course of TLR2 
stimulation in IFN-γ-treated macrophages (Fig. 3a). IFN-γ also suppressed 4E-BP1 
phosphorylation in TLR-stimulated human monocyte-derived dendritic cells 
(Supplementary Fig. 3a). In macrophages IFN-γ suppressed 4E-BP1 phosphorylation 
comparably or slightly more strongly than the well established allosteric inhibitor of 
mTORC1 rapamycin (Fig. 3b), which only partially inhibits mTORC1 but has strong 
biological effects related to suppression of mTORC1 function23. The ATP-competitive 
inhibitors of mTOR kinase activity, Torin1 and PP242, more strongly suppressed 4E-BP1 
phosphorylation, as expected. IFN-γ also suppressed phosphorylation of p70S6K, another 
substrate of mTORC1 that is involved in translation regulation (Fig. 3c, lane 6 vs. lane 1; 
50.5% mean suppression in 4 independent experiments, p=0.0031). These data show that 
IFN-γ suppresses phosphorylation of mTORC1 substrates important in regulation of 
translation, and support a role for IFN-γ in repressing mTORC1 activity.
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mTORC1 suppresses autophagy, a critical cellular process that degrades cytoplasmic 
proteins and organelles under conditions of nutrient deprivation18. Autophagy is 
characterized by autophagosome formation and generation of the proteolyzed form of 
autophagosome markers LC3A and LC3B24. IFN-γ induced comparable generation of the 
proteolyzed isoforms LC3A-II and LC3B-II as did rapamycin (Fig. 3d). These results 
further support that IFN-γ inhibits mTORC1 activity and suggest that one functional 
outcome of such inhibition is increased autophagy, which promotes microbial killing and 
antigen presentation24. Inhibition of mTORC1 resulted in increased inflammatory cytokine 
production (Supplementary Fig. 3b), supporting the notion that attenuation of mTORC1 
activity by IFN-γ contributes to its activating functions. mTORC1 activation occurs on 
lysosomal membranes and requires recruitment of mTORC1 to late endosomes and 
lysosomes by the Ragulator-Rag complex18, 25. We used immunofluorescence microscopy 
to test whether IFN-γ affected localization of mTOR to lysosomes. Control macrophages 
exhibited prominent colocalization of staining for mTOR and the lysosome and late 
endosome marker LAMP1 (Fig. 3e, upper panels). In contrast, IFN-γ-treated macrophages 
exhibited a clear dissociation of mTOR and LAMP1 staining (Fig. 3e, lower panels; p = 
0.0001). Collectively, reduced 4E-BP1 and p70S6K phosphorylation, enhanced autophagy, 
and disruption of mTOR lysosomal localization converge to the same conclusion that IFN-γ 
suppresses mTORC1 activity in human macrophages.
The results that IFN-γ suppressed mTORC1 activity and in parallel suppressed HES1 
translation suggested that translation and expression of HES1 protein might depend on 
mTORC1 signaling. We tested this prediction using rapamycin to inhibit mTORC1 and 
measured HES1 by immunoblot. Rapamycin inhibited TLR2-induced expression of HES1 
protein in a dose dependent manner (Fig. 3f) but had no effect on HES1 mRNA 
(Supplementary Fig. 3c). Thus, mTORC1 activity is required for translation of HES1 
mRNA into protein. These results link the inhibition of mTORC1 activity by IFN-γ with 
IFN-γ-mediated suppression of HES1 translation and provide an additional functional 
outcome of suppression of mTORC1 by IFN-γ.
IFN-γ suppresses localization of mTORC1 to lysosomes
Next we sought to identify mechanisms by which IFN-γ inhibits mTORC1 in human 
macrophages. mTORC1 activation requires dual inputs, one from the extracellular 
environment, typically mediated by growth factor-PI3K-Akt-TSC1/2-Rheb signaling, and a 
second from intracellular nutrient availability, typically conveyed by amino acid-mediated 
activation of the Ragulator-Rag complex that recruits mTORC1 to lysosomal membranes, 
where mTOR is activated by GTP-binding protein Rheb (Supplementary Fig. 3d). We 
wished to elucidate how IFN-γ suppressed the localization of mTORC1 to lysosomes, as 
was observed above. We thus investigated whether IFN-γ regulates the amino acid pathway 
of mTORC1 activation. The most potent amino acid activator of mTORC1 recruitment is 
leucine26, but mTORC1 activation is also partially dependent on tryptophan and certain 
additional amino acids27. Measurement of intracellular amino acid concentrations using 
ninhydrin reaction-based colorimetric detection analysis showed that intracellular 
concentrations of most amino acids, including leucine, were not notably diminished, 
although this technique does not detect tryptophan in our system (data not shown). IFN-γ is 
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a strong inducer of indoleamine 2,3-dioxygenase (IDO), which catalyzes tryptophan 
degradation and has been shown to deplete extracellular tryptophan and thus suppress 
lymphocyte proliferation28, 29. We reasoned that IFN-γ might induce sufficient IDO 
expression in human macrophages to deplete intracellular tryptophan and thereby suppress 
mTORC1 activity. We observed that IFN-γ strongly induces IDO expression with sustained 
kinetics in our system (Fig. 4a). Direct measurement of intracellular tryptophan and its 
catabolites by HPLC followed by mass spectrometry revealed striking depletion of 
tryptophan (70% decrease after IFN-γ priming) with parallel accumulation of its catabolites 
in the IDO-mediated degradation pathway (Fig. 4b and Supplementary Fig. 3e-f). To test 
whether this IDO-mediated depletion of intracellular tryptophan contributes to reduced 
mTORC1 activity we treated cells with IDO inhibitor 1-D-MT and performing 
immunofluorescence microscopy (Fig. 4c). 1-D-MT restored the colocalization of mTOR 
and LAMP1 in IFN-γ-treated macrophages (Fig. 4c, lower panels; p = 0.0008). Furthermore, 
addition of exogenous tryptophan to IFN-γ-treated cells also partially recovered the 
lysosomal distribution of mTOR (Fig. 4c), supporting that IDO-mediated depletion of 
tryptophan was responsible for IFN-γ-induced mTOR subcellular redistribution, although it 
is possible that tryptophan metabolites could also contribute to modulation of mTORC1 
activity. To further establish the role of IDO in regulating mTORC1 activity, we used 
mTORC1-dependent HES1 protein expression as a downstream readout of mTORC1 
signaling. Consistent with its reversal of IFN-γ-mediated suppression of mTORC1 
lysosomal localization (Fig. 4c), 1-D-MT reversed IFN-γ-mediated suppression of HES1 
protein expression (Fig. 4d lanes 5-8, p = 0.0003). Consistent with this and with restoration 
of lysosomal localization of mTOR (Fig. 4c), supplementation of tryptophan partially 
restored HES1 expression in IFN-γ-treated macrophages in a dose-dependent manner (Fig. 
4e). Taken together, these data implicate depletion of intracellular tryptophan by IDO in 
IFN-γ-mediated suppression of mTORC1 localization to lysosomes and thus suppression of 
mTORC1 activity.
IFN-γ suppresses mTORC1 activation by extracellular cues
Inhibition of lysosomal localization of mTOR by IFN-γ was not complete (Fig. 3e) and was 
only partially reversed by 1-D-MT or Trp (Fig. 4), suggesting IFN-γ also inhibits another 
pathway required for mTORC1 activity. Thus we considered the possibility that IFN-γ also 
suppresses PI3K-Akt-TSC signaling (Supplementary Fig. 3d). PI3K-Akt-TSC signaling is 
a major regulator of mTOR activity in response to extracellular factors, such as growth 
factors, and is also activated by inflammatory stimuli such as TLR ligands30. We found that 
TLR2-induced Akt phosphorylation was attenuated by IFN-γ (Fig. 5a). The PI3K inhibitor 
LY294002 abrogated Akt phosphorylation, confirming this inducible phosphorylation was 
due to PI3K activation (Fig. 5a). To corroborate suppression of Akt signaling by IFN-γ, we 
measured downstream induction of β-catenin, which is dependent on Akt-GSK3 signaling. 
The accumulation of β-catenin induced by TLR2 signaling was effectively inhibited by IFN-
γ, further supporting that IFN-γ inhibits Akt signaling (Fig. 5b). Akt activates mTORC1 by 
phosphorylating and thereby deactivating the negative regulator TSC2. Consistent with 
suppression of Akt signaling, IFN-γ also suppressed TSC2 phosphorylation (Fig. 5c). These 
results indicate that IFN-γ attenuates TLR2-activated signals that lead to Rheb-mediated 
activation of mTORC1 (Supplementary Fig. 3d). We also tested whether IFN-γ could 
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inhibit signaling by growth factors that maintain basal mTORC1 activity in macrophages by 
stimulating Akt activity. First, we confirmed that serum components and M-CSF 
(macrophage colony stimulating factor) were key factors for maintaining basal mTORC1 
activity in human macrophages (Supplementary Fig. 4a, b). M-CSF promotes Akt 
signaling; although basal Akt phosphorylation was difficult to detect secondary to limited 
sensitivity of immunoblotting, we found that IFN-γ effectively blocked M-CSF-induced Akt 
phosphorylation in macrophages that had been serum- and M-CSF-starved for 4 hours (Fig. 
5d). These results indicate that IFN-γ suppresses activation of mTORC1 by extracellular 
factors by suppressing the activation of Akt.
We investigated mechanisms by which IFN-γ suppresses growth factor-mediated Akt 
signaling in macrophages. We found that IFN-γ suppressed the expression of M-CSFR 
(CSF1R) mRNA and protein (Fig. 5e), which corroborated previous results31. Decreased M-
CSFR expression could explain diminished Akt activation by M-CSF and had minimal 
effect on cell survival under IFN-γ-primed conditions (Supplementary Fig. 4c). IFN-γ-
mediated suppression of TLR2-induced Akt activation was mediated by an okadaic acid-
sensitive phosphatase (Supplementary Fig. 2g) but was not associated with changes in 
phosphatases SHIP or PTEN that regulate this pathway (data not shown); future work will 
address how IFN-γ suppresses TLR2-induced Akt phosphorylation. To investigate 
mechanisms by which IFN-γ suppresses M-CSFR expression, we tested the role of Myc, 
which has been previously shown to promote mTORC1 activity in lymphocytes, although 
underlying mechanisms have not been fully clarified. We found that Myc and M-CSFR 
expression were induced during culture of cells with M-CSF (Fig. 5f and 5g), and inhibition 
of Myc with the compound 10058-F4 suppressed induction of M-CSFR expression (Fig. 
5g), suggesting that Myc is required for M-CSFR expression and mTORC1 activity in 
macrophages. Consistent with this notion, inhibition of Myc effectively suppressed 4E-BP 
phosphorylation (Fig. 5h), and also the downstream induction of mTORC1-dependent HES1 
protein expression (Supplementary Fig. 4d); similar results were obtained when Myc 
expression was knocked down using siRNA (Supplementary Fig. 4e). IFN-γ suppressed 
Myc expression (Fig. 5f and 5i). These results suggest that IFN-γ suppresses expression of 
the transcription factor Myc to downregulate M-CSFR expression and downstream activity 
of mTORC1, and identifies regulation of Myc as a link between IFN-γ and cell metabolism. 
Collectively, the results indicate that IFN-γ suppresses Akt signaling and thereby attenuates 
signals from extracellular factors that are required for mTORC1 activity (Supplementary 
Fig. 3d). This attenuation of signaling, working cooperatively with decreased recruitment of 
mTORC1 to lysosomal membranes (Fig. 3e), can explain strong inhibition mTORC1 
activity by IFN-γ.
Genome-wide analysis of translational regulation by IFN-γ
The MNK-eIF4E and 4EBP-eIF4E pathways that were suppressed by IFN-γ selectively 
regulate translation7, 10, 11, 12, and translational regulation is important for inflammatory 
responses7. To address the broad functional role of IFN-γ-regulated translation in 
inflammatory responses in primary human macrophages, we used a genome-wide approach 
combining high throughput RNA sequencing with ribosome profiling. Ribosome profiling 
provides a snapshot of the translatome by quantifying ribosome-protected RNA fragments 
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(RPF), the frequency of which on each transcript reflects the translation rate of the 
corresponding mRNA32. We quantified and compared the abundance of mRNA (counts per 
million reads (cpm)) and actively translated mRNA (RPF (cpm)) in TLR2-activated 
macrophages that had been treated with or without IFN-γ in two biological replicates 
(Supplementary Fig. 5a-b and Online Methods). For each of 9290 genes that passed 
stringency cut-offs (Online Methods), we calculated the translational efficiency (TE) by 
dividing the change in RPF reads by the change in cpm; this identifies changes that are 
solely attributable to changes in translation rate. As expected, IFN-γ treatment altered the 
abundance of multiple mRNA transcripts (Fig. 6a, x axis, 2976 mRNAs changed by > 2-
fold). IFN-γ also induced significant changes in translational efficiency in almost one 
thousand genes (Fig. 6a, y axis (z-score cut-off ±1.5) and Supplementary Fig. 5c), of 
which 396 genes were strongly affected (greater than 2-fold changes in TE). In contrast to 
consistent translational repression of most mRNAs upon complete inhibition of mTOR23, 
the effects of IFN-γ on translation were bidirectional, and IFN-γ increased and decreased TE 
of comparable numbers of genes (Fig. 6a and Supplementary Fig. 5c). Thus, ribosome 
profiling revealed an unappreciated role of IFN-γ in modulating translation of mRNA at a 
genome-wide level.
We wished to confirm our genome wide findings by analyzing individual genes and to 
corroborate regulation by IFN-γ of transcripts that are known to be targeted at the 
translational level by mTORC1. We examined the ribosome occupancy pattern on the well-
established mTOR target gene PABPC123, 33 (Fig. 6b, gene tracks of normalized RPF and 
RNA levels (c.p.m.)). Consistent with the depletion of PABPC1 mRNA from polysomes and 
decreased protein but not mRNA expression in IFN-γ-treated macrophages (Figure 1d, e), 
the ribosome footprint tag density across the message was suppressed (Fig. 6b, upper 2 
tracks) while the RNAseq read profile remained unchanged (Figure 6b, lower 2 tracks). In 
addition, RPF read tag density was diminished at the mTORC1 target genes PABPC3, 
PABPC4 and EEF2 (Fig. 6c), although mRNA levels did not change as assessed by RNAseq 
and qPCR (data not shown). Polysome shift analysis confirmed translational repression of 
PABPC3 and PABPC4 by IFN-γ (Figure 6d), and also showed translational repression of 
IRF7 (Fig. 6d), an immunologically important gene previously shown to be dependent on 
4E-BPs11. RPF read track density was suppressed in the translated portion of the mRNA for 
mTORC1 target HES1 (Supplementary Fig. 5d). Canonical mTORC1 target mRNAs 
possess a hallmark oligopyrimidine (TOP) motif immediately after the 5’cap and mainly 
encode factors that comprise protein synthesis machinery33. To gain insights into the overall 
influence of IFN-γ on mTORC1 targets, 65 established TOP mRNAs were analyzed. We 
analyzed genome-wide the relationship between IFN-γ-induced changes in mRNA and in 
RPF read density (which measures the summed effects of changes in mRNA and TE). For 
all genes, the correlation between changes in mRNA and RPF density was strong (Fig. 6e, 
R2 = 0.86), which is consistent with the results in Fig. 6a that mRNA levels are regulated 
over a broader dynamic range and a smaller subset of genes is regulated translationally. For 
5’TOP mRNAs, both mRNA and RPF read density were suppressed, but the correlation 
between the two was weaker (Fig. 6e, R2 = 0.65), suggesting that IFN-γ regulates the 
translation of mTORC1 target mRNAs to a greater extent than non-targets. Taken together, 
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ribosome profiling and polysome shift analysis demonstrated that IFN-γ inhibits the 
translation of some mTORC1-dependent mRNAs.
To gain additional insight into the functional role of IFN-γ-mediated translational regulation 
during inflammatory macrophage activation, we performed pathway and gene ontology 
(GO) analysis of genes that were regulated at the level of mRNA (c.p.m.), translation (TE), 
and RPF reads; changes in RPF reads reflect a combination of mRNA and translational 
regulation and are considered a better predictor of protein abundance32, 34 and thus IFN-γ 
function. Ingenuity pathway analysis (IPA) of ribosome profiling data (RPF reads) revealed 
highly statistically significant regulation of well-known IFN-γ-mediated pathways important 
in immune responses, such as antigen presentation (Fig. 7a, red bars and Table 1). IPA 
analysis also identified highly statistically significant negative regulation of mTOR 
signaling, eIF4 signaling and tRNA charging (Fig. 7a, blue bars and Table 1). The patterns 
of pathway enrichment were consistent among biological replicates and the combined 
dataset (Supplementary Fig. 6a). These results are in accord with a feed forward loop 
described in other systems whereby proteins important for translation are themselves 
regulated at the translational level33. Thus, translational dampening of eIF4 pathway 
components likely cooperates with signaling attenuation (Figs. 2, 3) to regulate eIF4 
function in IFN-γ-treated macrophages. The suppression of tRNA charging was particularly 
striking as translation of 29 out of 36 detected aminoacyl tRNA synthetases was suppressed 
(Supplementary Fig. 6b). This included leucyl-tRNA-synthetase (LARS), recently 
described as a direct amino acid sensor that recruits mTORC1 to the lysosomal surface and 
mediates its leucine-dependent activation35. Suppression of LARS expression was 
confirmed using immunoblotting (Fig. 7b, 62% mean suppression in 3 independent 
experiments, p = 0.013). Decreased LARS expression would contribute to the decreased 
mTORC1 localization to lysosomal membranes shown in Fig. 4. Collectively, our ribosome 
profiling results reveal that the cellular translational machinery might represent an 
unrecognized target for negative regulation by IFN-γ.
We next addressed the question of whether IFN-γ-induced changes in TE generally reinforce 
or oppose and modulate the overall IFN-γ response, as measured in an integrated manner by 
RPF reads. We analyzed the relationship between changes in TE and changes in RPF reads 
(Fig. 7c). Overall, the correlation between these two values was low (Pearson correlation 
coefficient R = 0.27, R2 = 0.072), suggesting that at the genome-wide level regulation of 
translation modulates and fine tunes the transcriptional response to IFN-γ. Consistent with 
this notion, of the genes with decreased RPF reads and significant changes in TE, 37% had a 
discordant increase in TE (Fig. 7c, left two quadrants). In contrast, of genes with increased 
RPF reads, the majority (77%) had a concordant increase in TE (Fig. 7c, right two 
quadrants, compare red and pink dots). Thus, IFN-γ-mediated increases in TE tend to 
reinforce and augment upregulation of gene expression. To analyze the function of genes 
regulated at the level of TE, we selected highly regulated genes (z-score=±1.5 in pooled data 
set) and stratified them into functional subcategories based on Gene Ontology 
(Supplementary Figure 7a, 7b). This analysis revealed that genes related to metabolic 
processes were the most enriched category among translation-regulated genes; immune 
genes were enriched as well (Supplementary Fig. 7; gene lists are shown in 
Su et al. Page 10









Supplementary Tables 1 and 2 and representative genes are shown in Fig. 7d). Strikingly, 
inflammatory cytokines and chemokines, such as IL-6, TNF, LTA, LTB, CXCL2 and 
CXCL3 were included in the immune gene group with increased TE (Fig. 7d, left panel). 
This suggests that translational regulation contributes to the previously described1 
augmentation of TLR-induced inflammatory responses by IFN-γ. Pathway analysis showed 
that metabolic process genes whose translation was increased were significantly associated 
with oxidative phosphorylation and mitochondrial pathways, genes whose translation was 
decreased were associated with stress pathways, and both sets of genes were associated with 
growth factor pathways (Supplementary Fig. 8a). Transporters of amino acids and other 
metabolites as well as RNA modification factors were among the genes most strongly 
downregulated by IFN-γ at the level of TE (Fig. 7d); additional investigation is required to 
discern the functional effects of translational regulation of these genes. Thus, IFN-γ 
regulates macrophage metabolism at the translational level. In summary, genome-wide 
ribosome profiling analysis indicates that IFN-γ changes the translational landscape of 
human macrophages, likely contributing to the inflammatory response and metabolic 
reprogramming.
Regulation of MNKs and mTORC1 can explain downregulation of translation by IFN-γ; we 
wished to investigate distinct mechanisms that could underlie increased translational 
efficiency of some mRNAs, such as IL-6 and TNF. IFN-γ modestly and transiently 
decreased phosphorylation of translation factor eIF2α (Supplementary Fig. 8b), which 
increases translation and could contribute to global maintenance of translation in IFN-γ-
treated cells and possibly to enhanced translation of specific transcripts. However, as 
regulation of eIF2α was modest, we tested the non-mutually exclusive hypothesis that IFN-γ 
could increase translational efficiency of select mRNAs by downregulating expression of 
microRNAs that suppress translation of these transcripts. We performed global profiling of 
miRNA expression in human primary macrophages using microRNAseq. 20 miRNAs were 
significantly induced by TLR2 stimulation in two independent experiments, including 
known regulators of inflammatory responses miR-155, miR-146a, miR-9 and miR-132 
(Supplementary Table 3). IFN-γ suppressed expression of 54 miRNAs by at least 2-fold in 
TLR2-stimulated macrophages (Fig. 8a, Supplementary Table 3 and data not shown). IFN-
γ suppressed expression of members of the let-7 miRNA family (Fig. 8a and 
Supplementary Table 4), which suppress inflammation by directly targeting IL-6 mRNA36. 
This observation supports the hypothesis that IFN-γ augments translation of inflammatory 
cytokines by suppressing miRNA expression. To analyze whether downregulation of 
additional miRNAs could contribute to increased TE of select transcripts, we integrated 
miRNA and ribosome profiling data to identify potential miRNA targets amongst all 
mRNAs with increased TE (Fig. 6a, z-score cut-off ±1.5) based on complementarity of 
3’UTR sequences to miRNA seed sequences. We focused on miRNAs most significantly (p 
< 1.3E−03, FDR<0.0653) downregulated by IFN-γ in TLR2-stimulated macrophages (Fig. 
8a and Table 2). Of these miRNAs, a majority had potential target mRNAs with increased 
TE; miR-146b-3p, a TLR2-induced miRNA that was suppressed 6 fold by IFN-γ, had 
several potential target mRNAs whose TE was increased by IFN-γ (Fig. 8b). Taken 
together, the results suggest that suppression of miRNA expression by IFN-γ may contribute 
to increased translation of certain mRNAs. Overall the results suggest that IFN-γ regulates 
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human macrophage metabolism and mRNA translation in an integrated manner to specify an 
activated phenotype (Supplementary Fig. 8c).
DISCUSSION
The profound activating effects of IFN-γ on macrophages have been predominantly 
attributed to transcriptional activation of ISGs, and its augmentation of inflammatory 
responses to signaling crosstalk and chromatin remodeling1, 6. In this study we found that 
IFN-γ alters macrophage metabolism by suppressing the central metabolic regulator 
mTORC1 and selectively alters mRNA translation to promote inflammation, further 
reprogram metabolic pathways, and modulate cellular translational machinery. Translational 
reprogramming was achieved by targeting mTORC1 and MNK pathways that are upstream 
of eIF4E, a factor that selectively regulates translation7, 10, 11. Conversely, genome-wide 
analysis showed that translational regulation modulated expression of genes important in 
metabolism. Thus, these newly described IFN-γ functions are tightly integrated to specify an 
activated macrophage phenotype. Inhibition of mTORC1 by pharmacological or genetic 
means has been previously shown to promote inflammation by suppressing STAT3 
activity19 and to augment microbial killing and antigen presentation, in part by increasing 
autophagy30, 37, 38. Thus, our findings provide insights into mechanisms by which 
physiological regulation of mTORC1 and translation by IFN-γ can contribute to hallmark 
IFN-γ functions such as boosting inflammatory responses and anti-microbial mechanisms. 
These findings also advance our understanding of reprogramming of cell states by IFN-γ to 
include metabolism and translation.
The importance of cellular metabolism is well established in adaptive immunity and is 
emerging in innate immunity39, 40, 41. Previous work on innate immune cells has focused 
TLR responses, which trigger a switch to aerobic glycolysis 42. Full inflammatory activation 
of macrophages by TLR ligands requires IFN-γ1, 43, and our signaling results and genome-
wide analysis of translational regulation suggest that extensive metabolic reprogramming 
contributes to IFN-γ -mediated polarization of macrophages, which will impact on how 
macrophages respond to subsequent environmental challenges.
IFN-γ suppressed mTORC1 in a physiological cell culture model using primary human 
macrophages that models the well known “priming” effects of IFN-γ that enhance responses 
to inflammatory factors and increase microbial killing1. Physiological regulation of 
mTORC1 by IFN-γ in human macrophages was partial, but comparable to that achieved by 
the allosteric mTORC1 inhibitor rapamycin. The level of mTORC1 inhibition achieved by 
rapamycin, and thus IFN-γ, has potent effects on immune responses and has been shown to 
augment innate responses in vitro and in vivo in mice and humans19, 20, 44, in part by 
augmenting inflammatory cytokine production and M1 polarization. Furthermore, partial 
mTORC1 suppression has been shown to enhance host defense against L. pneumophila38 
and pathogenic Shigella, in the latter case by augmenting autophagic clearance 
mechanisms37. This work supports the biological importance of the newly described 
regulation of mTORC1 by IFN-γ and helps link our findings with canonical IFN-γ functions. 
Overall, our results are in accord with the literature suggesting a suppressive role for 
mTORC1 in innate immunity19, 20, 37, 38. However, as a negative feedback loop induced by 
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constitutive mTORC1 activity in TSC1 knock out mice can augment cytokine production45, 
and mTOR has been linked to trained innate immunity46, the function of mTORC1 in innate 
immunity is context dependent and likely determined by the absence or presence of an IFN-
γ response and concomitant ISG expression.
Investigation of translational regulation by interferons has predominantly focused on type I 
IFNs, which globally suppress translation by suppressing eIF2α and by direct effects of 
ISGs13, 14, 15. Regulation of translation by IFN-γ has been primarily investigated in cell line 
models of cellular transformation16. Interestingly, in transformed cells IFN-γ, and also type I 
IFNs, directly but transiently activate Akt-mTORC1 and MNK-eIF4E signaling, resulting in 
increased ISG mRNA translation and thus augmentation of the early phase of the IFN 
response16. In contrast, we have not observed the early phase of Akt or MNK activation by 
IFN-γ in primary human macrophages; instead, IFN-γ suppresses Akt-mTORC1 and MNK-
eIF4E at later time points by indirect mechanisms such as inhibition of M-CSFR expression. 
Thus, the effects of IFN-γ on Akt-mTORC1 and MNK-eIF4E signaling are dependent on 
cell context and increase with duration of IFN-γ exposure. A striking contrast between 
translational effects of IFN-γ and type I IFNs is the selective regulation of translation of only 
a subset of expressed mRNAs by IFN-γ, which may be explained by selective regulation of 
translation by eIF4E7. In contrast, suppression of eIF2α by type I IFNs has more global 
effects14. A modest increase in eIF2α activity by IFN-γ may contribute to enhanced 
translation of specific transcripts, as could downregulation of miRNAs that suppress 
translation. Overall our work establishes mechanisms by which IFN-γ downregulates 
translation and provides insights into mechanisms by which IFN-γ could augment 
translation of select mRNAs.
This study describes the first, to our knowledge, comprehensive genome-wide translational 
profiling analysis in primary immune cells and in terminally differentiated nonproliferating 
cells. Analysis of genome-wide data revealed several functions for IFN-γ-mediated 
translational regulation in macrophages. First, IFN-γ-induced changes in translational 
efficiency (TE) were superimposed on changes in mRNA abundance to selectively modulate 
expression of different gene sets. Second, regulation of translational efficiency potentiated 
inflammatory activation by augmenting production of inflammatory proteins (TNF, IL-6, 
lymphotoxins) while decreasing production of anti-inflammatory feedback inhibitors (IL-10, 
HES1). Third, by suppressing expression of components of the translational machinery, 
IFN-γ could potentiate previously proposed ‘translational skewing’ towards highly 
expressed transcripts that favors host defense38, although our genome-wide analysis 
showing selective translational regulation suggests the translational skewing model38, 47 
may need to be refined to take into account properties of specific transcripts. Fourth, 
translational regulation by IFN-γ broadly impacted on proteins in metabolic pathways. Fifth, 
IFN-γ-mediated translational downregulation of multiple tRNA synthases by may have 
important consequences for macrophage activation as these proteins have various 
noncanonical functions independent of their aminoacyl transferase activity48.
In summary, the present study reveals that IFN-γ regulates mTORC1 and mRNA translation 
in an integrated manner in human macrophages. This regulation and associated changes in 
intracellular metabolism are linked with key IFN-γ functions such as potentiation of 
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inflammatory activation and autophagy, which is related to microbial killing. These findings 
extend our understanding of the role of metabolic regulation in innate immune cell 
activation, identify new functions for translational regulation by IFN-γ, and suggest 




Primary human CD14+ monocytes were isolated from buffy coats purchased from the New 
York Blood Center using anti-CD14 magnetic beads (MiltenyiBiotec) as previously 
described3, using a protocol approved by the Hospital for Special Surgery Institutional 
Review Board. Monocytes were cultured in RPMI 1640 (Invitrogen) medium supplemented 
with 10% (vol/vol) FBS (Hyclone) and macrophage colony stimulating factor (M-CSF) (20 
ng/ml). IFN-γ (100 U/ml) was added at the initiation of cultures and maintained for at least 
24 h prior to subsequent stimulations or harvesting cells.
Reagents and Antibodies
Human IFN-γ and S7 micrococcal nuclease were purchased from Roche; human M-CSF 
was from Peprotech; Pam3CSK4 was from EMC Microcollections; UltraPure E.Coli LPS 
was from Invivogen. MG132, CGP57380, Rapamycin and PP242 were purchased from 
Calbiochem; Cycloheximide, Bafilomycin A1, 1-Methyl-D-tryptophan (1-D-MT), L-
Tryptophan and 10058-F4 were from Sigma; Torin 1 was from R&D Systems; LY 294002 
was from EMD Millipore. The following antibodies were purchased from Cell Signaling: 
mTOR (#2983), p-TSC2(Thr1462) (#3617), TSC2 (#4308), p-Akt (Ser473) (#4060), p-
p70S6K(Thr421/Ser424) (#9204), 4E-BP1 (#9644), p-4E-BP1(Thr37/46) (#2855), LC3A 
(#4599), LC3B (#3868), IκB-α (#9242), Mnk1(#2195), p-Mnk1(Thr197/202) (#2111), 
eIF4E (#9742), p-eIF4E(Ser209) (#9741), p-p38(Thr180/Tyr182) (#9215), p-ERK1/2 
(Thr202/Tyr204) (#9101), ERK (#9102), β-catenin (#9562), M-CSFR (#3152). Additionally, 
p38α (sc-535), HES1 (sc-25392), TBP (sc-204), LAMP1 (sc-20011) and Myc (sc-764) were 
from Santa Cruz Biotech. PABPC1 (ab6125), β-tubulin (ab11307) and Leucyl tRNA 
synthetase (ab31534) antibodies were from Abcam. mirVana miRNA isolation kit was 
purchased from Ambion/Life Technologies. BD™ Cytometric Bead Array (CBA) human 
inflammatory cytokine kit was purchased from BD Biosciences.
RNA extraction and quantitative PCR
Total RNA was extracted from cells using RNeasy Mini kit (Qiagen), and 500 ng of total 
RNA was reverse transcribed using the RevertAid First Strand cDNA Synthesis kit 
(Fermentas). Real-time PCR was performed in triplicate with Fast SYBR Green Master Mix 
and 7500 Fast Real-time PCR system (Applied Biosystems).
Oligonucleotide primers for human transcripts were as follows:
(Forward primer, reverse primer, listed 5’ > 3’)
GAPDH: ATCAAGAAGGTGGTGAAGCA, GTCGCTGTTGAAGTCAGAGGA.
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Preparation of nuclear extracts
Pefabloc (Roche, 0.5 mg/mL) was added to cells 15 min prior to harvest. Cytoplasmic and 
nuclear extracts were obtained by incubating cells in Buffer A (10 mM HEPES pH 7.9, 1.5 
mM MgCl2, 10 mM KCl, 1 mM DTT, supplemented with protease inhibitor cocktail 
(Roche, 1X)) for 15 min on ice. The plasma membrane was then solubilized by incubation 
with NP-40 (0.2%) for 2 min. The nuclear pellet was obtained by centrifugation at 10,000×g 
for 30 s; supernatants corresponded to cytoplasmic lysates. Nuclear lysates were obtained by 
directly lysing nuclear pellets in 1× SDS-PAGE loading buffer.
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All samples for immunoblotting were denatured at 95 °C for at least 10 min. Denatured cell 
lysates were fractionated on 7.5% or 10% or 12% polyacrylamide gels using SDS-PAGE 
and transferred to polyvinylidene difluoride membranes for probing. Western Lightning® 
Plus-ECL, Enhanced Chemiluminescence Substrate (PerkinElmer) was used for detection. 
Images shown in figure panels were derived from one gel. In Figure 5h intervening lanes 
were spliced out and a white vertical line indicates lanes that were noncontiguous on the gel.
RNA interference
Immediately after isolation, primary human monocytes were nucleofected with On-Target 
plus SMARTpool short interfering RNAs (siRNA) purchased from Dharmacon Inc. 
(Lafayette, Colorado, USA) specific for MNK1, MNK2 or MYC. Non-targeting siRNA#5 
was used as control. Human Monocyte Nucleofector buffer (Lonza Cologne, Cologne, 
Germany) and the AMAXA Nucleofector System program Y001 for human monocytes were 
used according to the manufacturer's instructions.
Immunofluorescence staining
Primary human macrophages were cultured on poly-D lysine-coated coverslips (BD 
Biosciences Discovery Labware) for 24 h in the presence or absence of IFN-γ (100 U/ml). 
Cells were fixed with 2% formaldehyde for 15 min at room temperature and were 
permeabilized with 0.1% Tween-20 (PBST) at room temperature for 10min. 5% goat serum 
(Santa Cruz (sc-2043)) was used for blocking at 37 °C for 1 h, and then cells were stained 
with rabbit antibody to mTOR (Cell Signaling 2983 (7C10)), and mouse antibody to 
LAMP-1 (Santa Cruz H4A3 sc-20011) simultaneously in the 4°C cold room for at least 12 
h. Alexa Fluor 488 goat anti-rabbit (Invitrogen) and Alexa Fluor 594 goat anti-mouse 
(Invitrogen) secondary antibodies were then used to detect mTOR and LAMP1 primary 
antibodies, respectively. Coverslips were mounted with Vectashield mounting medium 
(Vector Laboratories) and images were obtained using a Nikon Eclipse Microscope.
Cytometric Bead Array (CBA) Assay
Culture supernatants of primary human macrophages as indicated in the figure legends were 
collected and processed immediately or snap frozen on dry ice for storage. Supernatant 
concentrations of secreted cytokines TNF, IL-6 and IL-10 were measured using BD 
Cytometric Bead Array (CBA) Human Inflammatory Cytokines Kit according to the 
manufacturer's instructions. Data were acquired on a BD FACS Canto flow cytometer; 
results were analyzed using FCAP Array software.
HPLC-MS analysis
For intracellular tryptophan and related metabolites measurement, samples were processed 
and analyzed by the Donald B. and Catherine C. Marron Cancer Metabolism Center at the 
Memorial Sloan Kettering Cancer Center. We harvested 10 million cells for each condition 
and quenched metabolism using 1ml of 80% methanol supplemented with 2μM D5-2HG. 
Protein was precipitated and removed by centrifugation. The samples were analyzed by 
Agilent 6230 time-of-flight (TOF) LC-MS instrument.
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To obtain enough material to generate high quality ribosome footprints, human primary 
macrophage lysates from different blood donors were pooled together (4 donors for replicate 
#1, 6 donors for replicate #2, Supplementary Fig 5a). Control or IFN-γ-treated human 
primary macrophages were stimulated for 4 h with Pam3CSK4 (10ng/ml), followed by 
cycloheximide (100 μg/ml) treatment for 7 min. We used the same pools of lysates for both 
RPFs (ribosome protected fragments) and RNA libraries construction. We followed a 
previously published protocol for ribosome profiling49 with the following modifications: S7 
micrococcal nuclease (120 U/ml) was used to generate mRNA-associated monosomes, and 
the monosomes were separated on sucrose density gradient followed by a sucrose cushion 
purification step to minimize the contamination of other protein-RNA complexes.
A modified reverse transcription primer (/phos/
NNNNNNNAGATCGGAAGAGCGTCGTGTAGGGAAAGAGT/idSp/
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTTTTTTTTTTTTTTTTTTTTVN) 
was designed to generate cDNA libraries. The first seven degenerate nucleotides were 
designed to monitor the clonal amplification bias from PCR. Both RPF and RNAseq 
libraries were sequenced on HiSeq 2000 platform.
Sequence alignment and annotation
The human genome sequence hg19 (Home_Sapiens.GRCh37.75.gtf) was downloaded from 
ensemble website (http//feb2014.archive.ensembl.org/downloads.html). A gtf file that only 
contains protein-coding genes was extracted based on the feature defined on the original gtf 
file. Before alignment, the first seven degenerate nucleotides were trimmed from 5’end; the 
polyA adapter at 3’end was removed by Clip; low quality reads were filtered out (mean 
quality score<20). rRNA contamination of ribosome protected fragments (RPF) was 
removed by Bowtie2 using the default setting. Both RPF and RNAseq reads were aligned to 
the genome sequence with Tophat2. The BAM files generated from Tophat2 were annotated 
with Htseq. Here we only analyzed protein-coding genes guided by gtf file described above. 
Genes that had less than 128 combined reads in two RNA libraries (control plus IFN-γ-
primed condition) of each biological replicate were removed for the reasons previously 
discussed32, 33. Reads that have multiple alignments were filtered out and cpm (counts per 
million) was calculated as cpm=106(Ci/N), where Ci is the number of reads mapped to 
exons of gene i, N is the number of mapped reads in the entire library including multiple 
aligned reads. Data sets from each replicate were analyzed either individually or merged by 
summing up the cpm for each condition. Translational efficiency (TE) was calculated as 
ratio of RPF and RNA (TE=RPF/RNA).
microRNA sequencing and data analysis
Control or IFN-γ-primed human primary macrophages from two independent donors were 
stimulated with or without Pam3CSK4 (10 ng/ml) for 4h. Total RNA was extracted using a 
mirVana miRNA isolation kit; miRNA libraries were prepared using TruSeq small RNA 
library prep kits (Illumina). Mirdeep2 was used to align the sequencing reads to human 
precursor miRNAs (miRBase release 21) as well as to calculate the read counts for each 
miRNA. Mature miRNAs with non-unique precursors were merged into one entry, and the 
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final expression values were normalized by library size (correspond to counts per million 
mapped miRNA reads). edgeR was used to merge the two biological replicates and 
statistical analysis was performed as previously described50. miRNAs of interest (e.g. 
miR-146-3p) were searched against conserved miRNA binding sites downloaded from 
TargetScan database (http://www.targetscan.org) to find target genes. Multiple sequence 
alignment with Clustal W was used to identify seed sequence binding sites with flanking 
regions in the 3’UTRs of genes showing increased translation efficiency.
Polysome profiling
Control or IFN-γ-treated human primary macrophages were stimulated for 4 h with 
Pam3CSK4 (10 ng/ml), followed by cycloheximide (100 μg/ml) treatment for 7 min. Cell 
pellets were lysed in polysome lysis buffer (20 mM Tris (pH 8.0), 140 mM NaCl, 15 mM 
MgCl2, 100μg /ml cyclohexmide, 0.5% Triton X-100 and protease inhibitor cocktail (Roche, 
1X)), followed by 5-6 passages through a 26G needle using a 1ml syringe. Cell lysates were 
gently laid onto 10%-50% sucrose density gradients to isolate polysome fractions. Gradients 
were centrifuged in a SW41 ultracentrifuge rotor at 35,000 r.p.m. for 2 h.
Statistics
The student t-test was used to analyze differences in experiments with two conditions; one-
way analysis of variance (ANOVA) followed by Bonferroni's multiple comparison post-test 
were used for experiments with more than two conditions. Statistical analyses were 
performed using GraphPad Prism 5.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. IFN-γ suppresses HES1 translation
(a) Quantitative PCR (qPCR) analysis of HES1 mRNA in human primary macrophages 
cultured with or without IFN-γ (100 U/ml) for 24 h and then stimulated with Pam3CSK4 (10 
ng/ml) for 0-6 h; results are normalized relative to GAPDH mRNA; Pam= Pam3CSK4. Data 
are shown as means + SD of triplicate determinants and are representative of more than 20 
independent experiments (cumulative results, Supplementary Fig. 1b). (b) Immunoblot 
analysis of HES1 in control or IFN-γ-treated macrophages stimulated with Pam3CSK4 (10 
ng/ml) for 0-4 h as indicated; p38α serves as a loading control; Pam= Pam3CSK4. Data are 
representative of 23 independent experiments. (c) Representative polysome profiles (left 
panel) of control (blue) or IFN-γ-treated (red) macrophages stimulated with Pam3CSK4 (10 
ng/ml) for 4 h. Quantitation (right panel) of ratio of RNA amounts in IFN-γ-treated relative 
to control conditions in the indicated fractions from three independent experiments (error 
bars, s.d.). Data are presented as mean ± SD and were analyzed using one way ANOVA, p = 
0.1383. (d) Polysome shift qPCR analysis of HES1, PABPC1 and ACTB mRNA in 
polysome fractions from (c), depicted as the percentage of mRNA in each fraction compared 
to total mRNA of all fractions (fractions 1-12). Data are representative of three independent 
experiments. (e) qPCR analysis (upper panel) of PABPC1 mRNA in control or IFN-γ-treated 
macrophages from two independent donors (error bars, s.d.); data are shown as means + SD 
of triplicate determinants. Immunoblot analysis (lower panel) of PABPC1 from parallel 
samples in the same experiments; p38α serves as loading control.
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Figure 2. IFN-γ inhibits TLR2-induced activation of MAPK-MNK-eIF4E axis
(a) Immunoblot analysis of phosphorylated (p-) eIF4E and p-MNK1 in control or IFN-γ-
primed macrophages treated with Pam3CSK4 (10 ng/ml) for 0-60 min; p38α serves as 
loading control. (b) Polysome shift analysis of NFKBIA mRNA. (c) Immunoblot analysis of 
HES1 in human primary macrophages pretreated for 30 min with the vehicle control 
dimethyl sulfoxide (DMSO) or increasing concentrations of MNK inhibitor CGP57380, then 
stimulated for 0, 2 or 4h with Pam3CSK4 (10 ng/ml); p38α serves as loading control. (d) 
qPCR analysis of HES1 mRNA in human primary macrophages (error bars, s.d.). 
UT=untreated; Pam= Pam3CSK4. Data are shown as means + SD of triplicate determinants 
and are normalized relative to GAPDH mRNA. (e) Immunoblot analysis of HES1 and 
phosphorylated (p-) eIF4E in human primary macrophages transfected with scrambled 
control small interfering RNA (siRNA) or siRNA specific for both MNK1 and MNK2 for 
72h, and then stimulated for 0-4 h with Pam3CSK4 (10 ng/ml); p38α serves as loading 
control. (f) Immunoblot analysis of phosphorylated (p-) p38 and p-ERK in control or IFN-γ-
primed macrophages treated with Pam3CSK4 (10 ng/ml) for 0-60 min; p38α and ERK serve 
as loading controls. (g) qPCR analysis of DUSP1, DUSP2, DUSP4, DUSP8 and DUSP16 
mRNA in control or IFN-γ-primed macrophages treated with or without Pam3CSK4 for 4h 
(error bars, s.d.). Data are shown as means + SD of triplicate determinants and are 
normalized relative to GAPDH mRNA. Data are representative of at least three independent 
experiments (a-g).
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Figure 3. IFN-γ suppresses mTORC1 activation and downstream functions
(a-c) Immunoblot analysis of whole cell lysates from control or IFN-γ-treated macrophages 
stimulated with Pam3CSK4 (10 ng/ml) for the indicated times and probed with antibodies 
against p-4E-BP1 (a, b) or p-p70S6K (c). In (b), mTOR inhibitors PP242 (50 nM ), Torin1 
(50 nM) or Rapamycin (500 nM) were added for 30 min. (d) Immunoblot analysis of LC3A 
and LC3B in control or IFN-γ-primed macrophages. (e) Upper: Immunofluorescence images 
of LAMP1 (red) and mTOR (green) co-staining in control or IFN-γ-primed macrophages 
stimulated with Pam3CSK4 (10 ng/ml) for 4 h; nuclei were stained with DAPI (blue). 
Quantitation of co-localization (lower panel) between LAMP1 and mTOR; data are 
presented as mean ± SEM of the percentage of co-localized cells from 600 cells analyzed in 
three independent experiments; * p = 0.0001 by unpaired student t test. (f) Immunoblot 
analysis of HES1 in human primary macrophages pretreated for 30min with vehicle control 
DMSO or increasing concentrations of Rapamycin (0 nM, 500 nM, 1 μM), and then 
stimulated with Pam3CSK4 (10 ng/ml) for 0, 2, or 4h; p38α serves as loading control. Data 
are representative of at least three independent experiments (a-e).
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Figure 4. IDO-mediated tryptophan depletion suppresses mTOR lysosomal localization and 
HES1 protein expression
(a) qPCR analysis of IDO1 mRNA in human primary macrophages treated with IFN-γ (100 
U/ml) for 0-24 h (error bars, s.d.). Data are shown as means + SD of triplicate determinants 
and are normalized relative to GAPDH mRNA. (b) HPLC-MS measurement of intracellular 
L-tryptophan concentration in control or IFN-γ-primed human primary macrophages treated 
with or without Pam3CSK4 (10 ng/ml) for 4h (error bars, s.d.). Data are shown as means + 
SD of triplicate determinants. (c) Upper panels: immunofluorescence images of LAMP1 
(red) and mTOR (green) co-staining in control macrophages (row 1), IFN-γ-primed 
macrophages (row 2), IFN-γ-primed macrophages pretreated for 30min with IDO inhibitor 
1-D-MT (200 μM) (row 3), and IFN-γ-primed macrophages supplemented with tryptophan 
(Trp) (800 μM) (row 4). All cells were stimulated with Pam3CSK4 (10 ng/ml) for 4 h; 
nuclei were counter-stained with DAPI (blue). Lower panel: quantitation of co-localization 
between LAMP1 and mTOR (error bars, s.e.m.). Data are presented as mean + SEM of the 
percentage of co-localized cells from 800 cells counted in two independent experiments; 
overall p = 0.0008 by one way ANOVA followed by Bonferroni's multiple comparison post-
test; *p<0.05, ** p<0.0001. (d, e) Immunoblot analysis of HES1 in control or IFN-γ-primed 
macrophages treated for 30min with 1-MT (200 μM) (d) or the indicated concentrations of 
tryptophan (Trp) (e), and then stimulated with Pam3CSK4 (10 ng/ml) for 4h; p38α serves as 
loading control. Data are representative of at least three (a, d, e) or two (b, c) independent 
experiments.
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Figure 5. IFN-γ inhibits PI3K-Akt-TSC1/2 signaling and M-CSFR expression
(a-c) Immunoblot analysis of whole cell lysates from control or IFN-γ-primed macrophages 
that were stimulated with Pam3CSK4 (10 ng/ml) for the indicated times. (d) Immunoblot 
analysis of phosphorylated (p-)Akt in control or IFN-γ-primed macrophages that were 
serum- and M-CSF-starved for 4 h, followed by pretreatment with vehicle control DMSO or 
LY294002 (10 μM) for 30 min, and then stimulated with M-CSF (100 ng/ml) for 0-30 min; 
Akt serves as loading control. (e) qPCR analysis (left panel) of CSF1R mRNA in control or 
IFN-γ-primed macrophages (error bars, s.d.). Data are shown as means + SD of triplicate 
determinants and are normalized relative to GAPDH mRNA. Immunoblot analysis (right 
panel) of M-CSFR in control or IFN-γ-primed macrophages; p38α serves as loading control. 
(f) qPCR analysis of MYC mRNA in monocytes cultured with M-CSF (20 ng/ml) with or 
without IFN-γ for indicated times (error bars, s.d.). Data are shown as means + SD of 
triplicate determinants and are normalized relative to GAPDH mRNA. (g) Immunoblot 
analysis of M-CSFR in human primary monocytes treated with vehicle control DMSO or 
Myc inhibitor 10058-F4 (60 μM) and then cultured with M-CSF (20 ng/ml) for indicated 
time points; p38α serves as loading control. (h) Immunoblot analysis of p-4E-BP1 in human 
primary monocytes treated with vehicle control DMSO or Myc inhibitor 10058-F4 (60 μM) 
for 30 min. (i) Immunoblot analysis of c-Myc in nuclear extracts of control or IFN-γ-primed 
macrophages that were stimulated with Pam3CSK4 (10 ng/ml) for 0-4h; TBP serves as 
loading control. Data are representative of at least three independent experiments (a-i).
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Figure 6. Genome-wide ribosome profiling analysis of IFN-γ-mediated translational regulation in 
macrophages
(a) Scatter plot comparing the changes in mRNA abundance (x axis) and translational 
efficiency (TE) (y axis) in response to IFN-γ; RNA fold change (x axis) = 
log2( RNAIFN-γ/RNAcontrol); TE fold change (y axis) = log2(TEIFN-γ /TEcontrol); mRNAs 
with suppressed TE (z-score <−1.5) or induced TE (z-score>1.5) are highlighted in blue or 
red, respectively. (b) Ribosome-protected fragment (RPF) and RNA-seq read density 
profiles for PABPC1 in control (tracks 1 and 3) and IFN-γ-primed (tracks 2 and 4) 
macrophages; data are normalized to total mapped reads in each library. (c) Ribosome-
protected fragments (RPF) read density profiles for PABPC3, PABPC4 and EEF2 in control 
(yellow) and IFN-γ-primed (purple) macrophages; data are normalized to total mapped reads 
in each library. (d) Polysome shift analysis of PABPC3, PABPC4 and IRF7 mRNA. (e) 
Scatter plot comparing the changes in mRNA abundance and ribosome footprint frequency; 
RNA (log2) = log2(RNAIFN-γ/RNAcontrol); RPF (log2) = log2(RPFIFN-γ/RPFcontrol); mRNAs 
with 5’ TOP elements are highlighted in green; Pearson correlation value (R) was calculated 
by GraphPrism. R2=0.65 for 65 established 5’ TOP genes; R2=0.86 for Non-TOP genes. 
Data (a, e) was generated from a merged dataset of two biological replicates, or is 
representative of two (b-c) or three (d) independent experiments.
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Figure 7. Selective translational inhibition of mRNAs involved in metabolic processes and 
protein synthesis by IFN-γ
(a) Ingenuity Pathway Analysis (IPA) of canonical pathways most enriched in sets of genes 
either up- (red) or down- (blue) regulated by IFN-γ at the level of ribosome footprint 
frequency (RPF); the y-axis indicates the –log10 (p-value) of each enriched pathway. (b) 
Immunoblot analysis of LARS in control or IFN-γ-primed macrophages; p38α serves as 
loading control. Data is representative of three experiments. (c) Scatter plot comparing the 
changes in ribosome footprint frequency and translational efficiency; RPF (log2) = 
log2(RPFIFN-γ/RPFcontrol); TE (log2) = log2(TEIFN-γ /TEcontrol); mRNAs with decreased TE 
(log2TE < −0.856) and decreased RPF (log2RPF < 0) are highlighted in dark blue; mRNAs 
with decreased TE (log2TE < −0.856) and increased RPF (log2RPF > 0) in light red; 
mRNAs with increased TE (log2TE > 0.578) and increased RPF (log2RPF > 0) in dark red; 
mRNAs with increased TE (log2TE > 0.578) and decreased RPF (log2RPF < 0) in light blue. 
(d) Heat map showing changes in RPF, RNA and TE of representative immune and 
metabolic process genes selected from gene sets identified by Gene Ontology (GO) analysis 
of translationally-regulated genes. GO analysis and entire enriched gene sets are shown in 
Supplementary Fig.7 and Supplementary Tables 1 and 2. Data (a, c, d) was generated from 
merged dataset of two biological replicates.
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Figure 8. IFN-γ downregulates miRNAs that target translationally upregulated genes
(a) Scatter plot showing normalized miRNA abundance of all conditions analyzed (x axis) 
and changes in miRNA expression induced by IFN-γ (y axis). Statistical analysis was 
performed using edgeR; the most significantly regulated genes are highlighted in red. (b) 
Potential target mRNAs of miR-146b-3p that are translationally upregulated by IFN-γ. * 
indicates 3’UTR sequence complementary to seed sequence of miR-146b-3p. Data shown 
was generated from merged dataset of two biological replicates.
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Table 1
IPA canonical pathways regulated by IFN-γ
Canonical pathways Up-regulated Down-regulated Not detected Total
EIF2 Signaling 9.9% 79.1% 11% 172
Antigen presentation pathway 70.3% 13.5% 16.2% 37
tRNA charging 2.6% 92.1% 5.3% 38
Purine nucleotides synthesis 0% 90.9% 9.1% 11
Regulation of eIF4 and p70S6K 12.7% 71.1% 16.2% 142
Crosstalk between DCs and NKs 41.6% 12.4% 46.1% 89
mTOR Signaling 13.7% 63.2% 23.1% 182
Ingenuity Pathway Analysis (IPA) of canonical pathways most enriched at the level of ribosome footprint frequency (RPF); ranked by P-value 
(indicated in Fig. 7a). The percentages of genes detected in each category (up- or down-regulated by IFN-γ, or not detected) are listed. Data was 
generated from merged dataset of two biological replicates.
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Table 2
miRNAs suppressed by IFN-γ
miRNA Expression (log2 fold) p-value FDR
hsa-miR-146b-3p –2.56 8.35E–07 0.0005
hsa-miR-4662a-5p –2.70 1.71E–06 0.0005
hsa-miR-99b-5p –2.27 3.89E–06 0.0008
hsa-miR-146b-5p –2.46 3.76E–05 0.0050
hsa-miR-654-3p –2.66 8.75E-04 0.0559
hsa-miR-125a-5p –1.56 8.96E-04 0.0559
hsa-let-7e-3p –1.98 1.30E-03 0.0653
miRNAs most significantly suppressed by IFN-γ in TLR-stimulated macrophages (p < 1.3E−03, FDR<0.0653). Expression (log2 fold) was 
calculated as relative miRNA expression by comparing IFN-γ-treated and control condition; Expression (log2 fold)=log2(IFN-γ/control) Statistical 
analysis was performed using edgeR.
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